首页> 外文期刊>Clinical Endocrinology >Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels
【24h】

Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels

机译:五肽胃泌素检测对基础降钙素水平适度升高的患者的C细胞增生与甲状腺髓样癌的术前鉴别诊断的预测价值

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Objectives Medullary thyroid carcinoma (MTC) is a calcitonin (CT)-secreting neuroendocrine tumour originating from thyroid C cells. Serum CT concentrations are helpful in the early detection of MTC, while it is still unclear whether they can be used also for the differential diagnosis between MTC and C-cell hyperplasia (CCH), a precancerous condition in familial MTCs but with unclear clinical significance in sporadic MTCs. Nowadays, surgery is recommended in all patients with basal or pentagastrin (PG)-stimulated CT value of 100 pg/ml or more, without discriminating if they are affected with MTC or CCH only. The objective of this study was to investigate the utility of the PG test for CT in distinguishing CCH from MTC before surgery.
机译:背景与目的甲状腺髓样癌(MTC)是一种分泌降钙素(CT)的神经内分泌肿瘤,起源于甲状腺C细胞。血清CT浓度有助于MTC的早期发现,但尚不清楚它们是否还可用于MTC和C细胞增生(CCH)的鉴别诊断,CCH是家族MTC的癌前状态,但在临床上尚无明确意义。零星的MTC。如今,建议对所有基底或五肽胃泌素(PG)刺激的CT值大于或等于100 pg / ml的患者进行手术,而不能区分他们是否仅受MTC或CCH影响。这项研究的目的是研究CT的PG测试在区分术前CCH和MTC方面的实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号